SEARCH

SEARCH BY CITATION

Keywords:

  • carboplatin;
  • gemcitabine;
  • paclitaxel;
  • renal medullary carcinoma

Abstract

Renal medullary carcinoma (RMC) is a rare and aggressive malignancy seen primarily in patients with sickle-cell trait. We report a complete response to carboplatin, paclitaxel, and gemcitabine in a patient with advanced metastatic RMC. Pediatr Blood Cancer. 2010;55:1217–1220. © 2010 Wiley-Liss, Inc.